Karyopharm Therapeutics Inc. (KPTI) Revenue by Year
Karyopharm Therapeutics Inc. generated $146.1M in revenue in fiscal year 2025. This represents an increase of 0.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $146.6M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Karyopharm Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KPTI Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $146.6M | $146.1M+0.6% | $145.2M-0.5% | $146.0M-7.0% | $157.1M-25.1% | $209.8M+94.1% | $108.1M+164.3% | $40.9M+34.8% | $30.3M+1790.1% | $1.6M+942.2% | $154K-38.4% | $250K+9.2% | $229K-40.8% | $387K-39.0% | $634K+317.1% | $152K |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
KPTI Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Karyopharm Therapeutics Inc. financials
Frequently Asked Questions
What was Karyopharm Therapeutics Inc.'s revenue in fiscal year 2025?
Karyopharm Therapeutics Inc. generated $146.1M in revenue in fiscal year 2025.
How fast is Karyopharm Therapeutics Inc.'s revenue growing?
Karyopharm Therapeutics Inc. (KPTI) revenue rose by 0.6% year over year, from $145.2M to $146.1M in fiscal year 2025.
What is Karyopharm Therapeutics Inc.'s revenue over the last twelve months?
Karyopharm Therapeutics Inc. (KPTI) reported $146.6M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Karyopharm Therapeutics Inc.'s revenue changed over the years?
Across the 15 fiscal years this page covers, Karyopharm Therapeutics Inc. (KPTI) revenue went from $152K in fiscal year 2011 to $146.1M in fiscal year 2025.
What was Karyopharm Therapeutics Inc.'s revenue in the most recent quarter?
Karyopharm Therapeutics Inc. (KPTI) reported $33.4M in revenue in Q2 2026. This represents a decrease of 11.9% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Karyopharm Therapeutics Inc. (KPTI) reported on that line in every period on record.